PurposeThe aim of this study was to evaluate visual and software-based quantitative assessment of parenchymal changes and normal lung parenchyma in patients with coronavirus disease 2019 (COVID-19) pneumonia. The secondary aim of the study was to compare the radiologic findings with clinical and laboratory data.MethodsPatients with COVID-19 who underwent chest computed tomography (CT) between March 11, 2020 and April 15, 2020 were retrospectively evaluated. Clinical and laboratory findings of patients with abnormal findings on chest CT and PCR-evidence of COVID-19 infection were recorded. Visual quantitative assessment score (VQAS) was performed according to the extent of lung opacities. Software-based quantitative assessment of the normal ...
BackgroundThe role of computed tomography (CT) in the diagnosis and characterization of coronavirus ...
Background: It remains unclear whether a specific chest CT characteristic is associated with the cli...
PURPOSE: We aimed to assess the severity of coronavirus disease 2019 (COVID-19) pneumonia on compute...
Purpose: the purpose of this study was to assess the evolution of computed tomography (CT) findings ...
Purpose: The purpose of this study was to assess the evolution of computed tomography (CT) findings ...
Purpose: To compare different commercial software in the quantification of Pneumonia Lesions in COVI...
Objective: To calculate by means of a computer-aided tool the volumes of healthy residual lung paren...
Objective: To calculate by means of a computer-aided tool the volumes of healthy residual lung paren...
Objective: To calculate by means of a computer-aided tool the volumes of healthy residual lung paren...
Objective: To investigate two commercial software and their efficacy in the assessment of chest CT s...
Objective: To investigate two commercial software and their efficacy in the assessment of chest CT s...
Background: So far, only a few studies evaluated the correlation between CT features and clinical ou...
Objective: To investigate two commercial software and their efficacy in the assessment of chest CT s...
Background Computed tomography (CT) of patients with severe acute respiratory syndrome coronavirus 2...
Rationale: Interpretation of lung abnormalities identified by computed tomography (CT) in patients w...
BackgroundThe role of computed tomography (CT) in the diagnosis and characterization of coronavirus ...
Background: It remains unclear whether a specific chest CT characteristic is associated with the cli...
PURPOSE: We aimed to assess the severity of coronavirus disease 2019 (COVID-19) pneumonia on compute...
Purpose: the purpose of this study was to assess the evolution of computed tomography (CT) findings ...
Purpose: The purpose of this study was to assess the evolution of computed tomography (CT) findings ...
Purpose: To compare different commercial software in the quantification of Pneumonia Lesions in COVI...
Objective: To calculate by means of a computer-aided tool the volumes of healthy residual lung paren...
Objective: To calculate by means of a computer-aided tool the volumes of healthy residual lung paren...
Objective: To calculate by means of a computer-aided tool the volumes of healthy residual lung paren...
Objective: To investigate two commercial software and their efficacy in the assessment of chest CT s...
Objective: To investigate two commercial software and their efficacy in the assessment of chest CT s...
Background: So far, only a few studies evaluated the correlation between CT features and clinical ou...
Objective: To investigate two commercial software and their efficacy in the assessment of chest CT s...
Background Computed tomography (CT) of patients with severe acute respiratory syndrome coronavirus 2...
Rationale: Interpretation of lung abnormalities identified by computed tomography (CT) in patients w...
BackgroundThe role of computed tomography (CT) in the diagnosis and characterization of coronavirus ...
Background: It remains unclear whether a specific chest CT characteristic is associated with the cli...
PURPOSE: We aimed to assess the severity of coronavirus disease 2019 (COVID-19) pneumonia on compute...